2004
DOI: 10.1074/jbc.m405137200
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a General Anesthetic Binding Site in the Diacylglycerol-binding Domain of Protein Kinase Cδ

Abstract: Protein kinase C (PKC) is an important signal transduction protein that has been proposed to interact with general anesthetics at its cysteine-rich diacylglycerol/ phorbol ester-binding domain C1, a tandem repeat of C1A and C1B subdomains. To test this hypothesis, we expressed, purified, and characterized the high affinity phorbol-binding subdomain, C1B, of mouse protein kinase C␦, and studied its interaction with general anesthetic alcohols. When the fluorescent phorbol ester, sapintoxin-D, bound to PKC␦ C1B … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

5
54
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 47 publications
(59 citation statements)
references
References 38 publications
5
54
0
Order By: Relevance
“…␣Met-236 and ␤Met-286 were labeled at similar levels (330 and 120 cpm/pmol) and with similar pharmacological specificity; i.e., enhancement by GABA and inhibition by ϳ90% in the presence of 200 M etomidate, consistent with the IC 50 value of 30 M seen for etomidate inhibition at the subunit level. In addition, azietomidate and other aliphatic diazirines preferentially label reactive side chains (Glu, Asp, and Tyr) in the nAChR and in soluble proteins (Pratt et al, 2000;Das et al, 2004;Ziebell et al, 2004). The lack of labeling of those side chains in ␣M1 (Tyr-225 and Tyr-231) and ␤M3 (Asp-282, Tyr-284, and Glu-298) provides evidence of the structural specificity of labeling and identifies regions in the TMD that do not contribute to the etomidate binding site.…”
Section: Discussionmentioning
confidence: 99%
“…␣Met-236 and ␤Met-286 were labeled at similar levels (330 and 120 cpm/pmol) and with similar pharmacological specificity; i.e., enhancement by GABA and inhibition by ϳ90% in the presence of 200 M etomidate, consistent with the IC 50 value of 30 M seen for etomidate inhibition at the subunit level. In addition, azietomidate and other aliphatic diazirines preferentially label reactive side chains (Glu, Asp, and Tyr) in the nAChR and in soluble proteins (Pratt et al, 2000;Das et al, 2004;Ziebell et al, 2004). The lack of labeling of those side chains in ␣M1 (Tyr-225 and Tyr-231) and ␤M3 (Asp-282, Tyr-284, and Glu-298) provides evidence of the structural specificity of labeling and identifies regions in the TMD that do not contribute to the etomidate binding site.…”
Section: Discussionmentioning
confidence: 99%
“…These probes share physicochemical properties with their parent molecules, retain anesthetic activity, and undergo photolysis under long wave ultraviolet light (UVA) (315-400 nm), a feature that limits damage to cellular macromolecules upon irradiation following equilibration with the ligands. With these compounds, anesthetic binding sites have been mapped on integrin lymphocyte function-associated antigen (3,6), Torpedo nicotinic receptors (7,8), ␤-tubulin (9), PKC (10), and GABA A receptors (11,12), among others. Direct identification of anesthetic substrates from complex homogenates has proceeded with a neurosteroid analog (2) and halothane (13), the latter an unaltered general anesthetic containing a carbon-bromine bond broken by shorter UV wavelengths to create reactive carbon-centered radicals (14).…”
mentioning
confidence: 99%
“…Azialcohols, bearing a photolabile diazirine moiety on one carbon, are stable general anesthetics with normal potencies that obey the MeyerOverton rule. Since their introduction (23), azialcohols have been used to locate binding sites on the nicotinic acetylcholine receptor (24), protein kinase C (25), and adenylate kinase (26).…”
mentioning
confidence: 99%